You are here

obesity

Arena, Orexigen and Vivus: An Update on Their Obesity Drugs

Seeking Alpha

Sat, 05/28/11 - 12:00 pm

Arena Pharmaceuticals

Arena shares rise on analysis of obesity drug data

Yahoo/AP

Fri, 05/27/11 - 08:57 am

Arena Pharmaceuticals

EnteroMedics Announces First Implant in ReCharge Pivotal Trial for Obesity

Wed, 05/18/11 - 06:24 pm

Vivus Still Looking for Ways to Push Diet Drug Forward

Seeking Alpha

Mon, 05/9/11 - 09:19 am

Vivus Puts Obesity Drug On A Diet

TheStreet.com

Tue, 05/3/11 - 09:02 am

EnteroMedics expects first sale of anti-obesity device by end of year

Mon, 04/25/11 - 11:32 pm

What Vivus Fails To Say About Its Diet Pill Study

Pharmalot

Tue, 04/12/11 - 10:06 am

Qnexa Trial Data is Good News for Vivus as Stock Rises

WSJ Online

Mon, 04/11/11 - 11:42 am

Vivus shares Qnexa study data

Yahoo/AP

Mon, 04/4/11 - 09:29 am

Novo Nordisk Patents Synthetic Gut Hormone in Obesity-Drug Plan

Bloomberg

Mon, 04/4/11 - 08:36 am

EnteroMedics Gets European Certification for Anti-Obesity Device

Thu, 03/31/11 - 12:58 pm

Lap Bands May Result in More Complications Than Weight Loss

Bloomberg

Tue, 03/22/11 - 09:22 am

Taking a Bite Out of Amylin's Obesity Drug Potential

Motley Fool

Thu, 03/17/11 - 11:29 pm

Amylin, Takeda Suspend Clinical Activities in Obesity Trial

Bloomberg

Wed, 03/16/11 - 11:59 am

Arena Pharmaceuticals: A Nail Biting Time for Lorcaserin Approval

Seeking Alpha

Mon, 03/14/11 - 11:22 am

Arena Pharmaceuticals

Analyst Notes: Vivus delivers Qnexa update

Yahoo/AP

Tue, 03/1/11 - 11:33 am

FDA Setbacks Make Vivus a Buying Opportunity

Seeking Alpha

Wed, 02/23/11 - 08:02 am

Is Orexigen Therapeutics Still a Good Buy?

Seeking Alpha

Mon, 02/7/11 - 11:27 am

New Hurdle for Orexigen Diet Pill Has Investors Worried

Seeking Alpha

Mon, 02/7/11 - 07:56 am

Heart Study Could Cost Twice Orexigen’s Market Cap

Forbes

Wed, 02/2/11 - 08:44 am

Pages